Cargando…
Level of Combined Estrogen and Progesterone Receptor Expression Determines the Eligibility for Adjuvant Endocrine Therapy in Breast Cancer Patients
SIMPLE SUMMARY: Patients whose breast cancers express low levels of hormone receptor (HR) could be eligible for adjuvant endocrine therapy; however, limited data are available to support this notion. Our retrospective study investigated the characteristics and survival of 6042 breast cancer patients...
Autores principales: | Ahn, Jee Hyun, Choi, Soon Bo, Park, Jung Min, Kim, Jee Ye, Park, Hyung Seok, Kim, Seung Il, Park, Byeong-Woo, Park, Seho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508141/ https://www.ncbi.nlm.nih.gov/pubmed/34638491 http://dx.doi.org/10.3390/cancers13195007 |
Ejemplares similares
-
Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
por: Choi, Soon Bo, et al.
Publicado: (2022) -
Lymphovascular invasion is an independent prognostic factor in breast cancer irrespective of axillary node metastasis and molecular subtypes
por: Lee, Suk Jun, et al.
Publicado: (2023) -
Is the frozen section examination for sentinel lymph node necessary in early breast cancer patients?
por: Yoon, Kwang Hyun, et al.
Publicado: (2019) -
Changes in Automated Mammographic Breast Density Can Predict Pathological Response After Neoadjuvant Chemotherapy in Breast Cancer
por: Ahn, Jee Hyun, et al.
Publicado: (2023) -
Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers
por: Kim, Hyung Sun, et al.
Publicado: (2016)